Dynamic changes in three biomarkers predict early-stage hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapy

被引:0
|
作者
Qianyu Zhu
Jialing Zhou
Hongyi Li
Hui Wang
Jiangbo Ren
Shujie Sun
Miaoran Yang
Shanshan Wu
Ming Cao
Kaixiang Wang
Hong You
Hong Ma
机构
[1] Beijing Friendship Hospital,Liver Research Center
[2] Capital Medical University,Molecular Biology Laboratory
[3] National Clinical Research Center for Digestive Diseases,undefined
[4] Baoding People’s Hospital,undefined
关键词
Biomarker; Hepatocellular carcinoma; Liver cirrhosis; Antiviral agent; Diagnosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:12691 / 12701
页数:10
相关论文
共 50 条
  • [31] Reduction of Cirrhosis and Hepatocellular Carcinoma With Antiviral Therapy in Chronic Hepatitis B Reply
    Lai, Ching-Lung
    Yuen, Man-Fung
    HEPATOLOGY, 2013, 58 (05) : 1857 - 1857
  • [32] Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B
    Lee, Jaemin
    Yoo, Sun Hong
    Sohn, Won
    Kim, Hyung Woo
    Choi, Yong Sun
    Won, Jung Ho
    Heo, Jin Young
    Park, Sang Jong
    Park, Young Min
    CLINICAL AND MOLECULAR HEPATOLOGY, 2016, 22 (03) : 339 - 349
  • [33] Longitudinal Assessment of Three Serum Biomarkers to Detect Very Early-Stage Hepatocellular Carcinoma
    Choi, Jonggi
    Kim, Gi-Ae
    Han, Seungbong
    Lee, Woochang
    Chun, Sail
    Lim, Young-Suk
    HEPATOLOGY, 2019, 69 (05) : 1983 - 1994
  • [34] A novel nomogram to predict the overall survival of early-stage hepatocellular carcinoma patients following ablation therapy
    Zhang, Honghai
    Sheng, Shugui
    Qiao, Wenying
    Han, Ming
    Jin, Ronghua
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [35] A Novel Nomogram to Predict Prognosis in Elderly Early-Stage Hepatocellular Carcinoma Patients After Ablation Therapy
    Tang, Xiaomeng
    Wang, Qi
    Jin, Ronghua
    Hu, Caixia
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2024, 11 : 901 - 911
  • [36] A MEDIATION ANALYSIS OF DYNAMIC PROCESS OF HEPATOCELLULAR CARCINOMA DEVELOPMENT IN CHRONIC HEPATITIS B PATIENTS WITH ANTIVIRAL TREATMENT
    Cho, Minjoo
    Choi, Jonggi
    Lee, Yeojin
    Hong, Hyeyeon
    Yang, Jiwon
    Chung, Sung Won
    Choi, Won-Mook
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Han, Seungbong
    HEPATOLOGY, 2023, 78 : S501 - S501
  • [37] A Machine Learning Model to Predict De Novo Hepatocellular Carcinoma Beyond Year 5 of Antiviral Therapy in Patients With Chronic Hepatitis B
    Ha, Yeonjung
    Lee, Seungseok
    Lim, Jihye
    Lee, Kwanjoo
    Chon, Young Eun
    Lee, Joo Ho
    Lee, Kwan Sik
    Kim, Kang Mo
    Shim, Ju Hyun
    Lee, Danbi
    Yon, Dong Keon
    Lee, Jinseok
    Lee, Han Chu
    LIVER INTERNATIONAL, 2025, 45 (04)
  • [38] Genomic characterization of early-stage hepatocellular carcinoma patients with Hepatitis B using circulating tumor DNA
    Lin, Daniel
    Luo, Rui
    Ye, Zhong
    Wei, Qiang
    Bae, Ho
    Juon, Hee-soon
    Hann, Hie Won
    Posey, James
    Wang, Chun
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2023, 47 (07)
  • [39] Impact of Antiviral Therapy on Risk Prediction Models for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
    Chon, Hye Yeon
    Lim, Tae Seop
    Jeon, MiYoung
    Lee, Hye Won
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    Kim, Seunq Up
    HEPATOLOGY, 2018, 68 : 1231A - 1232A
  • [40] Risk assessment of hepatocellular carcinoma in chronic hepatitis B patients with long-term antiviral therapy
    Chung, Kyu Sik
    Kim, Do Young
    Kim, Beom Kyung
    Kim, Seung Up
    Park, Jun Yong
    Ku, Hye Jin
    Han, Kwang-Hyub
    Ahn, Sang Hoon
    HEPATOLOGY, 2015, 62 : 385A - 385A